United Therapeutics (UTHR) Non-cash Items (2011 - 2020)

United Therapeutics has disclosed Non-cash Items across 10 years of filings, most recently posting $74.1 million for Q1 2020.

• Non-cash Items for Q1 2020 came in at $74.1 million, up 1807.1% year-over-year; the trailing twelve-month figure through Mar 2020 was $74.1 million (up 1807.1% YoY), and the FY2019 annual result was $90.1 million, up 175.54% from the prior year.
• Non-cash Items came in at $74.1 million for Q1 2020 at United Therapeutics, down from $90.1 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $124.0 million in Q1 2017 to a low of $3.1 million in Q3 2017.
• The 5-year median for Non-cash Items is $39.2 million (2016), against an average of $45.1 million.
• Across the five-year window, Non-cash Items slumped 96.8% in 2019 and surged 1807.1% in 2020, its largest moves.
• United Therapeutics' Non-cash Items stood at $39.2 million in 2016, then surged by 159.69% to $101.8 million in 2017, then sank by 67.88% to $32.7 million in 2018, then jumped by 175.54% to $90.1 million in 2019, then dropped by 17.76% to $74.1 million in 2020.
• The last three Non-cash Items figures came in at $74.1 million (Q1 2020), $90.1 million (Q4 2019), and $8.4 million (Q3 2019), per Business Quant data.